Edward D. Zanders

1.9k total citations
56 papers, 1.5k citations indexed

About

Edward D. Zanders is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Edward D. Zanders has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 24 papers in Molecular Biology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Edward D. Zanders's work include Monoclonal and Polyclonal Antibodies Research (16 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (9 papers). Edward D. Zanders is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (9 papers). Edward D. Zanders collaborates with scholars based in United Kingdom, United States and Finland. Edward D. Zanders's co-authors include Thomas Lehner, Jonathan R. Lamb, Michael W. Russell, Lesley A. Bergmeier, David Bailey, Marc Feldmann, Peter C. L. Beverley, Fredrik Svensson, Ronald A. Butow and P. Terpstra and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Biotechnology.

In The Last Decade

Edward D. Zanders

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward D. Zanders United Kingdom 24 578 568 238 229 178 56 1.5k
Daniel J. Slade United States 20 818 1.4× 501 0.9× 61 0.3× 137 0.6× 306 1.7× 38 1.5k
Joseph T. Newman United States 19 381 0.7× 594 1.0× 246 1.0× 82 0.4× 252 1.4× 44 1.5k
Benjamin D. Ehst United States 14 384 0.7× 1.6k 2.8× 154 0.6× 56 0.2× 290 1.6× 30 2.2k
Adam Lesner Poland 26 1.1k 1.9× 553 1.0× 47 0.2× 61 0.3× 337 1.9× 125 2.1k
Viktor A. Bokisch United States 18 474 0.8× 1.2k 2.1× 469 2.0× 223 1.0× 171 1.0× 23 2.1k
Elena Fernández‐Ruiz Spain 24 598 1.0× 923 1.6× 58 0.2× 48 0.2× 255 1.4× 44 2.1k
R M Jack United States 19 370 0.6× 499 0.9× 135 0.6× 176 0.8× 91 0.5× 34 1.1k
Toru Kawamoto Japan 26 715 1.2× 269 0.5× 114 0.5× 59 0.3× 649 3.6× 67 2.1k
Nancy Hurtado‐Ziola United States 13 1.1k 1.9× 797 1.4× 286 1.2× 103 0.4× 97 0.5× 13 1.9k
Robert E. Humphreys United States 25 892 1.5× 1.6k 2.7× 699 2.9× 98 0.4× 506 2.8× 111 2.6k

Countries citing papers authored by Edward D. Zanders

Since Specialization
Citations

This map shows the geographic impact of Edward D. Zanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward D. Zanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward D. Zanders more than expected).

Fields of papers citing papers by Edward D. Zanders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward D. Zanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward D. Zanders. The network helps show where Edward D. Zanders may publish in the future.

Co-authorship network of co-authors of Edward D. Zanders

This figure shows the co-authorship network connecting the top 25 collaborators of Edward D. Zanders. A scholar is included among the top collaborators of Edward D. Zanders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward D. Zanders. Edward D. Zanders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zanders, Edward D., Fredrik Svensson, & David Bailey. (2019). Therapy for glioblastoma: is it working?. Drug Discovery Today. 24(5). 1193–1201. 100 indexed citations
2.
Zanders, Edward D.. (2015). Human Drug Targets. 3 indexed citations
3.
Zanders, Edward D.. (2012). Chemical genomics and proteomics : reviews and protocols. Humana Press eBooks. 5 indexed citations
4.
Zanders, Edward D.. (2011). Overview of Chemical Genomics and Proteomics. Methods in molecular biology. 800. 3–10. 4 indexed citations
5.
Zanders, Edward D.. (2011). The Science and Business of Drug Discovery. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 4 indexed citations
6.
Bailey, David G. & Edward D. Zanders. (2008). Drug discovery in the era of Facebook—new tools for scientific networking. Drug Discovery Today. 13(19-20). 863–868. 14 indexed citations
7.
Zanders, Edward D.. (2005). Chemical genomics : reviews and protocols. Humana Press eBooks. 3 indexed citations
8.
Zanders, Edward D., et al.. (2005). The emergence of chemical genomics in drug discovery.. PubMed. 8(11). 919–23. 1 indexed citations
9.
Davies, Nicholas, Mahlet G. Tadesse, Marina Vannucci, et al.. (2004). Making Sense of Molecular Signatures in The Immune System. Combinatorial Chemistry & High Throughput Screening. 7(3). 231–238. 2 indexed citations
10.
Zanders, Edward D., David Bailey, & Philip M. Dean. (2002). Probes for chemical genomics by design. Drug Discovery Today. 7(13). 711–718. 21 indexed citations
11.
Dopazo, Joaquı́n, et al.. (2001). Methods and approaches in the analysis of gene expression data. Journal of Immunological Methods. 250(1-2). 93–112. 53 indexed citations
12.
Dean, Philip M., Edward D. Zanders, & David Bailey. (2001). Industrial-scale, genomics-based drug design and discovery. Trends in biotechnology. 19(8). 288–292. 38 indexed citations
13.
Bailey, David, Edward D. Zanders, & P. Dean. (2001). Site-specific molecular design and its relevance to pharmacogenomics and chemical biology. The Pharmacogenomics Journal. 1(1). 38–47. 2 indexed citations
14.
Bailey, David, Edward D. Zanders, & P. Dean. (2001). The end of the beginning for genomic medicine. Nature Biotechnology. 19(3). 207–209. 16 indexed citations
15.
Zanders, Edward D., et al.. (2000). Analysis of immune system gene expression in small rheumatoid arthritis biopsies using a combination of subtractive hybridization and high-density cDNA arrays. Journal of Immunological Methods. 233(1-2). 131–140. 34 indexed citations
16.
Champion, Brian, et al.. (1991). Secondary immunoglobulin responses of BALB/c mice previously stimulated with goat anti-mouse IgD.. PubMed. 72(3). 336–43. 2 indexed citations
17.
Fattah, Dilniya, et al.. (1990). In vitro and in vivo studies with purified recombinant human interleukin 5. Cytokine. 2(2). 112–121. 34 indexed citations
18.
Larché, Mark, et al.. (1988). Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor.. PubMed. 65(4). 617–22. 30 indexed citations
19.
Lamb, Jonathan R., Edward D. Zanders, William A. Sewell, et al.. (1987). Antigen‐specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathways. European Journal of Immunology. 17(11). 1641–1644. 35 indexed citations
20.
Zanders, Edward D. & Thomas Lehner. (1981). Separation and Characterization of a Protein Antigen from Cells of Streptococcus mutans. Microbiology. 122(2). 217–225. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026